Nanohydroxyapatite composites' toxicity and biosafety for safe clinical translation
Nanoscale Advances · 2026 · 8 (18) · 5016-5041
DOI: 10.1039/d6na00491a ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Nanoscale Advances, 2026. Verfasst von Shikha Awasthi. Beteiligte Einrichtung: Jagran School of Pharmacy, Jagran Lakecity University Bhopal - 462044 Madhya Pradesh India awas.shikha2212@gmail.com. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 129 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0).
Abstract (Originalsprache)
nHAp composites are promising, but these composites can trigger a number of toxicity-related responses depending on the particle characteristics, composite composition, dosage, and biological exposure conditions (the figure was created using BioRender).
Autor:innen und Institutionen
- Jagran School of Pharmacy, Jagran Lakecity University Bhopal - 462044 Madhya Pradesh India awas.shikha2212@gmail.com.
ORCID-Profile: Shikha Awasthi
Zitieren
APA
Awasthi, S. (2026). Nanohydroxyapatite composites' toxicity and biosafety for safe clinical translation. Nanoscale Advances, 8(18), 5016-5041. https://doi.org/10.1039/d6na00491a
Vancouver
Awasthi S. Nanohydroxyapatite composites' toxicity and biosafety for safe clinical translation. Nanoscale Advances. 2026;8(18):5016-5041. doi:10.1039/d6na00491a
BibTeX
@article{Awasthi2026,
author = {Awasthi, Shikha},
title = {Nanohydroxyapatite composites' toxicity and biosafety for safe clinical translation},
journal = {Nanoscale Advances},
year = {2026},
volume = {8},
number = {18},
pages = {5016--5041},
doi = {10.1039/d6na00491a}
}
EUVIMED